Abstract
THE past decade has seen an alarming worldwide increase in resistance to β-lactam antibiotics among many pathogenic bacteria1, which is due mainly to plasmid- or chromosomally encoded p-lactamases that specifically cleave penicillin and cephalosporins, rendering them inactive. There is therefore a need to develop new strategies in the design of effective inhibitors of β-lactamase. All the small-molecule inhibitors in clinical use are not very effective and are rapidly degraded2,3. Furthermore, newly characterized mutants of the plasmid-mediated β-lactamase TEM-1 are highly resistant to these small-molecule inhibitors, including clavulanic acid and tazobactam4. It has been shown that Streptomyces clavuligerus produces an β-lactamase inhibitory protein (BLIP; MT 17.5 K)5. Here we present data defining BLIP as the most effective known inhibitor of a variety of β-lactamase, with Ki values in the subnanomolar to picomolar range. To identify those features in BLIP that make it such a potent inhibitor, we have determined its molecular structure at 2.1 Å resolution. BLIP is a relatively flat molecule with a unique fold, comprising a tandem repeat of a 76-amino-acid domain. Each domain consists of a helix–loop–helix motif that packs against a four-stranded antiparallel β-sheet (Fig. la). To our knowledge, BLIP is the first example of a protein inhibitor having two similarly folded domains that interact with and inhibit a single target enzyme.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Neu, H. C. Science 257, 1064–1072 (1992).
Reading, C. & Cole, M. Antimicrob. Agents Chemother. 11, 852–857 (1977).
Reading, C. & Hepburn, P. Biochem. J. 179, 67–76 (1979).
Blazquez, J., Baquero, M.-F., Canton, R., Alos, R. & Bagnew, F. Antimicrob. Agents Chemother. 37, 2059–2067 (1993).
Doran, J. C., Leskiw, B. K., Aippersbach, S. & Jensen, S. E. J. Bact. 172, 4904–4918 (1990).
Sougakoff, W., Goussard, S., Gerbaud, G. & Courvalin, P. Rev. Infect. Dis. 10, 879–884 (1988).
Strynadka, N. C. J. et al. Nature 359, 700–705 (1992).
Jelsch, C., Mourey, C., Masson, J-M. & Samama, J-P. Prot. Struct. Func. Genet. 16, 364–383 (1993).
Herzberg, O. J. molec. Biol. 217, 701–719 (1991).
Knox, J. R. & Moews, P. C. J. molec. Biol. 220, 435–455 (1991).
Kim, Y., Geiger, J. H., Hahn, S. & Sigler, P. B. Nature 365, 512–520 (1993).
Kim, J. C., Nikolov, D. B. & Burley, S. K. Nature 365, 520–527 (1993).
Read, R. J. & James, M. N. G. in Proteinase Inhibitors Ch. 5 (eds Barret, A. J. & Salvensen, G.) 301–336 (Elsevier, Amsterdam, 1986).
Laskowski, M. & Kato, I. A. Rev. Biochem. 49, 593–626 (1980).
Bush, K. Antimicrob. Agents Chemother. 33, 264–271 (1989).
Frère, J.-M., Leyh-Bouille, M., Ghuysen, J.-M., Nieto, M. & Perkins, H. R. Meth. Enzym. 45, 610–636 (1976).
Kabsch, W. & Sanders C. Biopolymers 22, 2577–2637 (1983).
Hamlin, R. Meth. Enzym. 114, 416–452 (1985).
Howard, A. J., Nielsen, C. & Xuong, N. H. Meth. Enzym. 114, 452–472 (1985).
Read, R. J. Acta crystallogr. A42, 140–149 (1986).
Brünger, A. T. XPLOR Manual, Version 1.5 (Yale Univ., New Haven, 1987).
Hendrickson, W. A. Meth. Enzym. 115, 252–270 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Strynadka, N., Jensen, S., Johns, K. et al. Structural and kinetic characterization of a β-lactamase-inhibitor protein. Nature 368, 657–660 (1994). https://doi.org/10.1038/368657a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/368657a0
This article is cited by
-
An active site loop toggles between conformations to control antibiotic hydrolysis and inhibition potency for CTX-M β-lactamase drug-resistance enzymes
Nature Communications (2022)
-
The hydrolytic water molecule of Class A β-lactamase relies on the acyl-enzyme intermediate ES* for proper coordination and catalysis
Scientific Reports (2020)
-
Efficient production of secretory Streptomyces clavuligerus β-lactamase inhibitory protein (BLIP) in Pichia pastoris
AMB Express (2018)
-
Detecting transitions in protein dynamics using a recurrence quantification analysis based bootstrap method
BMC Bioinformatics (2017)
-
Systematic substitutions at BLIP position 50 result in changes in binding specificity for class A β-lactamases
BMC Biochemistry (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.